PremiumThe FlyCelularity files to sell 6.52M shares of Class A common stock, warrants MASS Coalition welcomes order freezing skin substitute LCDs Celularity Faces Challenges as Agreement Expires PremiumThe FlyCelularity strategic partner announces stem cell, regenerative medicine center Celularity resolves Nasdaq listing compliance issue Celularity raises FY24 revenue view to $54M-$60M from $50M-$56M PremiumCompany AnnouncementsCelularity Board Member Marc Mazur Announces Resignation Celularity sees Q2 net sales of biomaterial product, biobanking $11M-$13M Celularity sees Q1 net sales of biomaterial product, biobanking $14.8M 
